MedTrace Logo

Quality of Life After Radiofrequency Ablation of Pancreatic Cancer

NCT02637596 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2015-12-28

No results posted yet for this study

Summary

A prospective clinical study evaluating quality of life (QoL) in pancreatic cancer patients treated with intraoperative radiofrequency ablation (RFA).

Conditions

Interventions

PROCEDURE

Radiofrequency ablation

After laparotomy, intraoperative IOUS quided RFA of primary tumor was performed.

Sponsors & Collaborators

  • Brno University Hospital

    lead OTHER

Principal Investigators

  • Jan Hlavsa, MD, PhD · Department of surgery Masaryk University Hospital Brno

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2014-01-31
Completion
2015-12-31

Countries

  • Czechia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02637596 on ClinicalTrials.gov